Investor Relations

hypgen investors

Market Potential

HL: The market is set to increase more than fourfold from $316 million in 2014 to $1.4 billion by 2024, representing a Compound Annual Growth Rate (CAGR) of 16%

AML: The AML global market was valued at USD 701.6 million in 2018, and is estimated to be valued at USD 1,539.99 million in 2024, witnessing a CAGR of 14%.

PD: The global PD therapeutics market was valued at US$ 2.18 Billion in 2016 and is projected to register a CAGR of more than 10.9% from 2017 to 2025

Stroke: The Global Stroke Diagnostics and Therapeutics market is expected to reach $49,698.98 million by 2026 growing at a CAGR of 7.9% during 2018 to 2026.

Downloadable Files

PhorMed Financial Statement – 2021
PhorMed Financial Statement – 2020
PhorMed Financial Statement – 2019

More to come…